Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer

Gastroenterology

Volumn 155, Issue 2, 2018, Pages 383-390.e8

  Kwong, Thomas N Y ^a   Wang, Xiansong ^a   Nakatsu, Geicho ^a   Chow, Tai Cheong ^a   Tipoe, Timothy ^a   Dai, Rudin Z W ^a   Tsoi, Kelvin K K ^a   Wong, Martin C S ^a   Tse, Gary ^a   Chan, Matthew T V ^a   Chan, Francis K L ^a   Ng, Siew C ^a   Wu, Justin C Y ^a   Wu, William K K ^a   Yu, Jun ^a   Sung, Joseph J Y ^a   Wong, Sunny H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Colon Cancer; Marker; Microbiome; Pathogen

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BACTEROIDES; BACTEROIDES FRAGILIS; CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS; CLOSTRIDIUM SEPTICUM; COHORT ANALYSIS; COLON BIOPSY; COLORECTAL CANCER; COMORBIDITY; DISEASE ASSOCIATION; FEMALE; FUSOBACTERIUM NUCLEATUM; GEMELLA; GEMELLA MORBILLORUM; GRANULICATELLA; HUMAN; HUMAN TISSUE; INTESTINE FLORA; MALE; NONHUMAN; PARVIMONAS; PEPTOSTREPTOCOCCUS; PREVOTELLA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLOBACTERIUM; STREPTOCOCCUS GALLOLYTICUS; BIOPSY; BLOOD; CARCINOGENESIS; COLON; COLORECTAL TUMOR; COMPARATIVE STUDY; DYSBIOSIS; HONG KONG; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; BACTEROIDES FRAGILIS; BIOPSY; CARCINOGENESIS; COLON; COLORECTAL NEOPLASMS; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; HONG KONG; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STREPTOCOCCUS GALLOLYTICUS;

EID: 85050468312     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2018.04.028     Document Type: Article

References (34)

1. Torre, L.A., Bray, F., Siegel, R.L., et al. Global cancer statistics, 2012. CA Cancer J Clin 65 (2015), 87–108.
2. Sobhani, I., Tap, J., Roudot-Thoraval, F., et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One, 6, 2011, e16393.
3. Yu, J., Feng, Q., Wong, S.H., et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 66 (2017), 70–78.
4. Zeller, G., Tap, J., Voigt, A.Y., et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol, 10, 2014, 766.
5. Castellarin, M., Warren, R.L., Freeman, J.D., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22 (2012), 299–306.
6. Nakatsu, G., Li, X., Zhou, H., et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun, 6, 2015, 8727.
7. Wong, S.H., Kwong, T.N.Y., Chow, T.C., et al. Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia. Gut 66 (2017), 1441–1448.
8. Liang, Q., Chiu, J., Chen, Y., et al. Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer. Clin Cancer Res 23 (2017), 2061–2070.
9. Wong, S.H., Zhao, L., Zhang, X., et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology 153 (2017), 1621–1633.e6.
10. Tsoi, H., Chu, E.S., Zhang, X., et al. Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice. Gastroenterology 152 (2017), 1419–1433.e5.
11. Wu, S., Rhee, K.J., Albesiano, E., et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15 (2009), 1016–1022.
12. Rubinstein, M.R., Wang, X., Liu, W., et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 14 (2013), 195–206.
13. Kostic, A.D., Chun, E., Robertson, L., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 14 (2013), 207–215.
14. Ellmerich, S., Scholler, M., Duranton, B., et al. Promotion of intestinal carcinogenesis by Streptococcus bovis. Carcinogenesis 21 (2000), 753–756.
15. Biarc, J., Nguyen, I.S., Pini, A., et al. Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S. bovis). Carcinogenesis 25 (2004), 1477–1484.
16. Friedrich, I.A., Wormser, G.P., Gottfried, E.B., The association of remote Streptococcus bovis bacteremia with colonic neoplasia. Am J Gastroenterol 77 (1982), 82–84.
17. Mirza, N.N., McCloud, J.M., Cheetham, M.J., Clostridium septicum sepsis and colorectal cancer—a reminder. World J Surg Oncol, 7, 2009, 73.
18. Boleij, A., van Gelder, M.M., Swinkels, D.W., et al. Clinical importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 53 (2011), 870–878.
19. Corredoira-Sanchez, J., Garcia-Garrote, F., Rabunal, R., et al. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study. Clin Infect Dis 55 (2012), 491–496.
20. Gupta, A., Madani, R., Mukhtar, H., Streptococcus bovis endocarditis, a silent sign for colonic tumour. Colorectal Dis 12 (2010), 164–171.
21. Grivennikov, S.I., Wang, K., Mucida, D., et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17–mediated tumour growth. Nature 491 (2012), 254–258.
22. West, N.R., McCuaig, S., Franchini, F., et al. Emerging cytokine networks in colorectal cancer. Nat Rev Immunol 15 (2015), 615–629.
23. Chiu, S.S., Lau, Y.L., Chan, K.H., et al. Influenza-related hospitalizations among children in Hong Kong. N Engl J Med 347 (2002), 2097–2103.
24. Ho, J., Dai, R.Z.W., Kwong, T.N.Y., et al. Disease burden of Clostridium difficile infections in adults, Hong Kong, China, 2006–2014. Emerg Infect Dis 23 (2017), 1671–1679.
25. Leung WK, Wong IO, Cheung KS, et al. Effects of Helicobacter pylori treatment on incidence of gastric cancer in older individuals. Gastroenterology https://doi.org/10.1053/j.gastro.2018.03.028. Epub ahead of print.
26. Claridge, J.E. III, Attorri, S., Musher, D.M., et al. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (“Streptococcus milleri group”) are of different clinical importance and are not equally associated with abscess. Clin Infect Dis 32 (2001), 1511–1515.
27. Abdulamir, A.S., Hafidh, R.R., Abu Bakar, F., The association of Streptococcus bovis/gallolyticus with colorectal tumors: the nature and the underlying mechanisms of its etiological role. J Exp Clin Cancer Res, 30, 2011, 11.
28. Abdulamir, A.S., Hafidh, R.R., Bakar, F.A., Molecular detection, quantification, and isolation of Streptococcus gallolyticus bacteria colonizing colorectal tumors: inflammation-driven potential of carcinogenesis via IL-1, COX-2, and IL-8. Mol Cancer, 9, 2010, 249.
29. Abed, J., Emgard, J.E., Zamir, G., et al. Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host Microbe 20 (2016), 215–225.
30. Norrby, K., Interleukin-8 and de novo mammalian angiogenesis. Cell Prolif 29 (1996), 315–323.
31. Dubrow, R., Edberg, S., Wikfors, E., et al. Fecal carriage of Streptococcus bovis and colorectal adenomas. Gastroenterology 101 (1991), 721–725.
32. Abdulamir, A.S., Hafidh, R.R., Mahdi, L.K., et al. Investigation into the controversial association of Streptococcus gallolyticus with colorectal cancer and adenoma. BMC Cancer, 9, 2009, 403.
33. Mima, K., Cao, Y., Chan, A.T., et al. Fusobacterium nucleatum in colorectal carcinoma tissue according to tumor location. Clin Transl Gastroenterol, 7, 2016, e200.
34. Zauber, A.G., Winawer, S.J., O'Brien, M.J., et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366 (2012), 687–696.